Literature DB >> 12446484

Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies.

Nancy D Borofsky1, Joseph H Vogelman, Rozlyn A Krajcik, Norman Orentreich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12446484

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  18 in total

1.  Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.

Authors:  Jennifer Ose; Helena Schock; Elizabeth M Poole; Matti Lehtinen; Kala Visvanathan; Kathy Helzlsouer; Julie E Buring; I-Min Lee; Anne Tjønneland; Marie-Christine Boutron-Ruault; Antonia Trichopoulou; Amalia Mattiello; N Charlotte Onland-Moret; Elisabete Weiderpass; María-José Sánchez; Annika Idahl; Ruth C Travis; Sabina Rinaldi; Melissa A Merritt; Nicolas Wentzensen; Shelley S Tworoger; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Causes Control       Date:  2017-02-16       Impact factor: 2.506

2.  Depressive symptoms are associated with allostatic load among community-dwelling older adults.

Authors:  Roni W Kobrosly; Edwin van Wijngaarden; Christopher L Seplaki; Deborah A Cory-Slechta; Jan Moynihan
Journal:  Physiol Behav       Date:  2014-01-17

Review 3.  The current status of IGF-I assays--a 2009 update.

Authors:  Jan Frystyk; Pamela Freda; David R Clemmons
Journal:  Growth Horm IGF Res       Date:  2009-10-08       Impact factor: 2.372

4.  Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study.

Authors:  Jason L Sanders; Wensheng Guo; Ellen S O'Meara; Robert C Kaplan; Michael N Pollak; Traci M Bartz; Anne B Newman; Linda P Fried; Anne R Cappola
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

5.  Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis.

Authors:  Melanie R Shapiro; Clive H Wasserfall; Sean M McGrail; Amanda L Posgai; Rhonda Bacher; Andrew Muir; Michael J Haller; Desmond A Schatz; Johnna D Wesley; Matthias von Herrath; William A Hagopian; Cate Speake; Mark A Atkinson; Todd M Brusko
Journal:  Diabetes       Date:  2019-12-11       Impact factor: 9.461

6.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Authors:  Timothy J Key; Paul N Appleby; Gillian K Reeves; Andrew W Roddam
Journal:  Lancet Oncol       Date:  2010-05-14       Impact factor: 41.316

7.  Associations of insulin and insulin-like growth factors with physical performance in old age in the Boyd Orr and Caerphilly studies.

Authors:  Kate Birnie; Yoav Ben-Shlomo; Jeff M P Holly; David Gunnell; Shah Ebrahim; Antony Bayer; John Gallacher; Richard M Martin
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

8.  Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk.

Authors:  Frank M Biro; Bin Huang; Halley Wasserman; Catherine M Gordon; Susan M Pinney
Journal:  J Adolesc Health       Date:  2020-09-01       Impact factor: 5.012

Review 9.  Normal levels of serum IGF-I: determinants and validity of current reference ranges.

Authors:  G Brabant; H Wallaschofski
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

10.  Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition.

Authors:  Julie A Schmidt; Naomi E Allen; Martin Almquist; Silvia Franceschi; Sabina Rinaldi; Sarah J Tipper; Konstantinos K Tsilidis; Elisabete Weiderpass; Kim Overvad; Anne Tjønneland; Marie-Christine Boutron-Ruault; Laure Dossus; Sylvie Mesrine; Rudolf Kaaks; Annekatrin Lukanova; Heiner Boeing; Pagona Lagiou; Dimitrios Trichopoulos; Antonia Trichopoulou; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Roberto Zanetti; H Bas Bueno-de-Mesquita; Petra H Peeters; Eiliv Lund; Virginia Menéndez; Antonio Agudo; María-José Sánchez; Maria-Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; Joakim Hennings; Maria Sandström; Kay-Tee Khaw; Nick Wareham; Isabelle Romieu; Marc J Gunter; Elio Riboli; Timothy J Key; Ruth C Travis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-19       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.